Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France
Table 8
Overall survival (months) by histologic category.
Histologic category
Total
Died, n (%)
Censored, n (%)
Mean
Median
95% CI
Leiomyosarcoma
229
132 (57.6)
97 (42.4)
27.2
23.8
20.3
27.4
Others/NOS
183
134 (73.2)
49 (26.8)
20.5
16.2
14.2
18.4
Fibroblastic/myofibroblastic sarcoma
78
55 (70.5)
23 (29.5)
19.7
19.2
13.5
22.8
Liposarcoma
105
78 (74.3)
27 (25.7)
34.8
16.3
13.3
21.0
Vascular sarcoma
79
54 (68.4)
25 (31.6)
26.7
15.2
10.4
22.0
Rhabdomyosarcoma
86
57 (66.3)
29 (33.7)
27.4
20.1
13.1
22.3
Synovial sarcoma
47
35 (74.5)
12 (25.5)
23.5
16.2
12.6
23.2
CI: confidence interval; NOS: not otherwise specified.
